论文部分内容阅读
目的探究淋巴瘤化疗间歇期随访路径表在淋巴瘤化疗患者院外随访中的应用效果。方法随机选取2016年1月~2017年1月我院血液科收治的淋巴瘤患者50例,分为对照组与观察组。对照组25例行常规随访;观察组25例使用《淋巴瘤化疗间歇期随访路径表》行阶段式随访。采用癌症病人生活质量评定量表(EORTC QLQ-C30)比较两组的生活质量。结果化疗前两组各项EORTC QLQ-C30评分比较,无统计学差异(P>0.05);第三个化疗间歇期,观察组各项评分均优于对照组,差异具有统计学意义(P<0.05)。结论间歇期随访路径表应用于淋巴瘤化疗患者的随访中,可及时了解患者情况,为患者持续提供监护与支持,有助于提高患者的生活质量,值得临床和护理技术推广、运用。
Objective To investigate the application effect of interictal follow-up pathologic table of lymphatic chemotherapy during the follow-up of patients with lymphoma chemotherapy. Methods Fifty patients with lymphoma admitted to Department of Hematology from January 2016 to January 2017 were randomly selected and divided into control group and observation group. Control group 25 routine follow-up; observation group 25 cases using “lymphoma chemotherapy intermittent follow-up path table” line stage follow-up. The quality of life of the two groups was compared using the Cancer Patients Quality of Life Rating Scale (EORTC QLQ-C30). Results There was no significant difference between the two groups before the chemotherapy EQTCQLQ-C30 score (P> 0.05); the third chemotherapy interval, the observation group scores were better than the control group, the difference was statistically significant (P < 0.05). Conclusion Intermittent follow-up path-table is applied to the follow-up of lymphoma patients with chemotherapy. Patients can be informed about the patient’s condition in time and the patient’s care and support can be continuously provided. This helps to improve the quality of life of patients and is worth popularizing and applying clinical and nursing techniques.